Vera Kondrashov
Physician Assistant · West Sacramento, CANPI 1689271587
Payments from drug & device makers
Across 73 payments — averaging $21.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$221
- Lilly USA, LLC$181
- Pfizer$131
- Novo Nordisk$126
- Merck$91
- Sumitomo Pharma America, Inc.$75
- plus $713 from 22 others
What the payments were for
- Food & beverage$1,539100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 11 | $221 |
| Lilly USA, LLC | 8 | $181 |
| Pfizer | 7 | $131 |
| Novo Nordisk | 7 | $126 |
| Merck | 4 | $91 |
| Sumitomo Pharma America, Inc. | 3 | $75 |
| AbbVie | 4 | $73 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $70 |
| Exact Sciences | 3 | $68 |
| Boehringer Ingelheim | 2 | $50 |
| Dexcom, Inc. | 2 | $50 |
| Sanofi-aventis U.S. LLC | 1 | $37 |
| Amgen | 2 | $34 |
| Boston Scientific | 2 | $34 |
| Agios Pharmaceuticals, Inc. | 1 | $27 |
| Bayer | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $26 |
| Johnson & Johnson | 1 | $25 |
| Ascensia Diabetes Care US Inc. | 1 | $24 |
| Gilead | 1 | $23 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Novartis | 1 | $20 |
| Medtronic | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $18 |
| Halozyme Inc | 1 | $18 |
| Lundbeck LLC | 1 | $14 |
| AstraZeneca | 1 | $14 |
How this compares
$1,539 in reported general payments places this provider in the 75th percentile of 10,423 physician assistant providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 15 | $24,684 |
| JanuviaSitagliptin Phosphate | 16 | $12,786 |
| TrulicityDulaglutide | 11 | $10,386 |
| Atorvastatin Calcium | 53 | $740 |
| Levothyroxine Sodium | 38 | $665 |
| Tamsulosin Hcl | 28 | $619 |
| Rosuvastatin Calcium | 13 | $568 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $532 |
| Metoprolol Succinate | 26 | $358 |
| Finasteride | 14 | $311 |
| Azelastine Hcl | 12 | $298 |
| Montelukast Sodium | 13 | $298 |
| Pioglitazone Hcl | 11 | $272 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 23 | $257 |
| Amlodipine Besylate | 35 | $239 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $50 | $24,68415 claims |
| MerckJanuvia | $91 | $12,78616 claims |
| Lilly USA, LLCTrulicity | $181 | $10,38611 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 10,423 physician assistant providers in California.
Other physician assistant in West Sacramento
- John QuigleyDowney$2.9M
- Andrea NguyenIrvine$1M
- Mikhail AlperMadera$889K
- Erin JensenUpland$716K
- Franklin ClineSacramento$458K
- Carla CrespoMarina del Rey$297K
- Katherine OsakiEl Centro$274K
- Shawna JonesFountain Valley$266K
- Heather AustinSalinas$219K
- Eric CheungLos Angeles$213K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.